Dr. Gregory T. Armstrong on Improved Outcomes for Childhood Cancer Survivors

Proper counseling is needed to help decrease fertility-related psychological distress in adolescent/young adult cancer survivors.

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

The FDA has approved bosutinib to treat pediatric patients with Philadelphia chromosome–positive, chronic-phase chronic myelogenous leukemia.

In this episode of "The Vitals," Ellen Miller, MSN, FNP-BC, talks about meeting a patient who realized she wanted to get pregnant after undergoing chemoradiation as a teenager.

Veno-occlusive disease or sinusoidal obstruction syndrome is commonly associated as a complication with transplant in pediatric patients but can also be seen with chemotherapy alone.

The FDA has granted blinatumomab full approval for patients with minimal residual disease–positive B-cell acute lymphoblastic leukemia.